Primary entity: SemaxClass: Synthetic neuropeptide — not FDA-approvedCluster: Nootropic neuropeptides
Semax is a synthetic heptapeptide analog of ACTH(4-10) discussed as a nootropic / neuroprotective research and (in Russia) medicinal peptide. It is not FDA-approved in the United States. “Nootropic peptide” marketing online should not be confused with U.S. approved cognitive drugs — see our Nootropics hierarchy.
Russian clinical use history is a real regulatory fact pattern — it does not create U.S. OTC or RUO legitimacy for DIY cognitive enhancement.
Not FDA-approved. Russia has medicinal Semax products in national frameworks; that is not FDA approval. U.S. gray-market nasal sprays/vials are a quality and legality literacy issue, not a dosing guide.
Covered by HHS's Oct 28, 2026 interim enforcement-discretion policy for licensed-pharmacy (503A) compounding: free-base form, intranasal only; single ingredient; valid prescription; conditions apply. Not FDA-approved in the U.S., not on the final bulks list, and not a green light for RUO products. Interim and revocable. See the compounding status guide.
Key takeaways
- Semax = synthetic ACTH(4-10) analog neuropeptide.
- Not FDA-approved; Russia-market use ≠ U.S. approval.
- Sits under nootropic peptides in our hierarchy — distinct from wakefulness stimulants like armodafinil.
- Often paired in forums with Selank — different peptide.
- No dosage / nasal-spray protocol charts here.
Questions this page answers
Next questions we answer on this page (curiosity / AI-gap map):
- What is Semax?
- Also known as
- Classification / hierarchy
- What it is NOT
- Mechanism literacy
- Evidence ladder
- What’s been studied
- Safety literacy
- Regulatory status
- Why no dosages
- Related nootropics
- Who for / not for
Who is this profile for — and who is it not for?
For: readers mapping nootropic peptides vs stimulants and needing Semax identity literacy.
Not for: anyone seeking cognitive-enhancement protocols, buy links, or medical advice.
What is Semax?
Semax is a synthetic peptide derived from the ACTH(4-10) fragment with structural modifications (commonly described as Met-Glu-His-Phe-Pro-Gly-Pro in literacy materials). It is discussed for CNS / cognitive research themes and has a history of medicinal use in Russia. Place it in taxonomy via the Nootropics hierarchy.
| Chemistry | Synthetic ACTH(4-10) analog peptide |
|---|---|
| U.S. FDA approval | No |
| Common folk class | Nootropic peptide |
| Hierarchy bucket | Neuropeptide nootropics (not a stimulant) |
| Common comparison | Selank (different peptide) |
Also known as
- Semax — primary name.
- ACTH(4-10) analog — structural literacy.
- N-acetyl / other salt/form variants may appear in commerce — identity still needs CoA literacy, not dosing advice.
It is not an amphetamine. Hierarchy: neuropeptide nootropic research/medicinal peptide ≠ classic stimulant wakefulness agent.
How is Semax classified?
Nootropic neuropeptide on this site’s hierarchy: peptide neuromodulator class, distinct from eugeroics (modafinil/armodafinil), actoprotector-like synthetics (bromantane), and research metabolic peptides. Not FDA-approved.
What is Semax not?
| Semax is not… | Why that matters |
|---|---|
| FDA-approved U.S. drug | No U.S. approval |
| Selank | Different peptide (often stacked in folklore) |
| Armodafinil / modafinil | Different chemistry and U.S. scheduling story |
| Something we dose or source | Refusal |
How is Semax thought to work?
Research discussions involve neurotrophic / neuromodulatory themes (including BDNF-related narratives in some literature) rather than classic amphetamine-like catecholamine release. Treat mechanism as literacy — not a guarantee of safe cognitive enhancement.
What human vs animal vs label evidence exists?
| Evidence type | What exists (summary) | Maturity |
|---|---|---|
| Human — Russian clinical contexts | National medicinal use literature of varying accessibility/quality | Human Context-limited — |
| Animal / cell | Neuroprotection / cognition models | Animal / Cell |
| U.S. approved label | None | None |
| Forum nootropic logs | Anecdote | None |
What has Semax been studied for?
Themes include cognitive / cerebrovascular / neuroprotective research narratives and Russian clinical indications historically associated with branded Semax products. Studied or used abroad ≠ U.S. approved indication.
What safety topics come up?
Without a U.S. label, there is no FDA prescribing-information package for consumer RUO use. Nasal vs other routes in folk use create product-quality and local-irritation literacy questions. Not medical advice.
What is Semax's regulatory status?
- U.S.: Not FDA-approved.
- Russia: Medicinal Semax products exist in national regulation.
- Sport: Check WADA/GlobalDRO for peptide hormones / related rules as applicable.
Why doesn't this page include a dosage chart?
Not FDA-approved; protocol-seeking “Semax dosage” queries. Literacy refusal. Hierarchy hub explains class — still no charts.
Related lab literacy
General peptide lab vocabulary only via how-to — not a Semax nasal protocol.
Related compounds and comparisons
- Selank — companion nootropic peptide.
- Bromantane — actoprotector-like synthetic (not a peptide).
- Armodafinil — FDA-approved eugeroic (not a peptide).
- Nootropics hierarchy.
Frequently asked questions
Is Semax FDA approved?
No.
Is Semax a stimulant like Adderall?
No. It is a neuropeptide; hierarchy places it away from classic amphetamine stimulants.
Semax vs Selank?
Different peptides. Semax is an ACTH(4-10) analog; Selank is a tuftsin-derived analog. See Selank profile.
Why is it on a peptide site?
It is a peptide with high nootropic SERP demand — mapped in our hierarchy.
Why no dosage chart?
YMYL + unapproved U.S. status.
Semax is not FDA-approved. Disclaimer.
Sources
- Primary — preclinical / translational Panikratova YR, Lebedeva IS, Sokolov OY, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020;490(1):9-11. doi:10.1134/S001249662001007X. PMID: 32342318.
- Primary — animal Filippenkov IB, Shpetko YY, Stavchansky VV, et al. ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke. Biomedicines. 2024;12(12):2830. doi:10.3390/biomedicines12122830. PMID: 39767736. Animal study.
- Internal Peptide Tutorials. Selank; Nootropics hierarchy; Disclaimers. Russia-market history is not FDA approval.
- Written by
- Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
- Published · Updated
- Oct 6, 2026 · Nov 10, 2026 · Labels, trial citations, and WADA list wording checked Nov 10, 2026 · How we source & update
Educational disclaimer: Educational only. No dosing or buy links. We don’t sell peptides. Read our full disclaimers.